The main category of All News Articles.

You can use the search box below to find what you need.

[wd_asp id=1]

19 12, 2025

GBPUSD Forecast: British Pound Battles “Moving Average Cluster” After Hawkish BoE Cut

By |2025-12-19T00:16:34+02:00December 19, 2025|Forex News, News|0 Comments

The GBPUSD pair has transformed into a technical battleground as the trading week nears its close. A combination of a divided Bank of England (BoE) and a cooling US inflation report has created a “whipsaw” environment, leaving the price resting precariously on a significant layer of technical support.

  • The BoE Catalyst: A narrow 5-4 vote for a “hawkish cut” by the Bank of England initially sparked Sterling strength, signaling that the path to future rate cuts remains steep.

  • The CPI Whipsaw: A soft US CPI print (2.7%) sent the pair to a multi-week high of 1.3446 before a massive retracement saw the pair surrender all daily gains.

  • The Technical Floor: The price is currently testing a “cluster” of four major moving averages between 1.3348 and 1.3380, a zone that will define the trend for the Friday close.

Breaking Down the Momentum: From Hawkish Cuts to Soft CPI

The initial leg of the GBPUSD rally was fundamentally driven. The Bank of England’s decision to cut rates—but with a clear 5-4 split—indicated to the markets that the BoE is not in a rush to ease aggressively. This “hawkish lean” gave the British Pound a head start against a softening Greenback.

Later, the US Consumer Price Index (CPI) added fuel to the fire. The weaker-than-expected inflation data triggered a sharp sell-off in the US Dollar, propelling the “Cable” above a series of key daily and hourly moving averages. This move saw the pair challenge the highs of the last two weeks, specifically testing the Tuesday peak near 1.3455.

The “Moving Average Cluster” Barometer

Despite the breakout, momentum failed to hold. The pair has retraced back into a dense zone where four critical moving averages are currently overlapping. This “cluster” acts as a massive technical pivot point:

As long as the price remains within or above this zone, the “Up and Down” volatility theme persists. The price action today reached as low as 1.3370 before stabilizing slightly, keeping the market in a state of high suspense.

The Roadmap: What to Watch for the Friday Close

As we transition into the final session of the week, the cluster of moving averages will serve as the primary barometer for directional bias.

The Bullish Scenario

For the buyers to reclaim the driver’s seat, they must keep the price sustained above the 1.33804 (100-hour MA). A push above the 1.3405 swing area is required to confirm that the bears have been flushed out. If successful, the door opens for another run toward the recent highs at 1.34526.

The Bearish Scenario

If the sellers gain enough traction to break below the bottom of the cluster at 1.33488 (200-day MA), the technical picture turns decidedly bearish. A break here would likely trigger a retest of the weekly low at 1.33118, with a secondary target at last week’s low and the key 38.2% Fibonacci retracement level of 1.32833.

Watch the Video Analysis

In the video above, Greg Michalowski, author ofAttacking Currency Trends, provides a deep dive into these GBPUSD technical levels. He breaks down the real-time price action, helps you define the bias, the risk, and the specific targets that will matter most today and going forward.

Be aware. Be prepared.

Source link

19 12, 2025

Synaptigen Review: Ingredients, Benefits, Safety, and Who It’s For – On Pattison

By |2025-12-19T00:07:34+02:00December 19, 2025|Dietary Supplements News, News|0 Comments


 

Synaptigen Review: An In-Depth Look at the Ingredients, Intended Benefits, and Who It May Be For

 

This article is provided for educational and informational purposes only and is not intended to replace individualized medical, nutritional, or professional advice. Many factors, including age, genetics, lifestyle, medications, and underlying health conditions can influence cognitive health. Readers are encouraged to consult a qualified healthcare professional before starting any new dietary supplement, especially if they are pregnant, nursing, taking medication, or managing a medical condition.

 

Synaptigen is a dietary supplement, not a medication. Statements about ingredients discussed in this article are based on publicly available research and are presented for general educational context only. Synaptigen as a finished product has not been clinically evaluated by the FDA, and individual results may vary.


 

Throughout this report, all product features, pricing, guarantees, and policies are attributed directly to the company’s official website as of publication and are subject to change. Readers are encouraged to verify details directly with the brand before making any purchase decisions.

 

Disclosure: If you register through this link, a commission may be earned at no additional cost to you.

 

Why Cognitive Changes Feel So Frustrating — And Why Many People Start Looking for Support


 

For many people, changes in memory, focus, or mental sharpness don’t happen all at once. They tend to show up quietly — a forgotten name here, a moment of mental fog there, or a growing sense that staying mentally sharp now takes more effort than it used to.

 

What often makes this experience frustrating isn’t just the change itself, but the uncertainty around it. Is this simply part of normal aging? Is it related to stress, sleep, nutrition, or daily habits? Or is it something that could potentially be supported with the right lifestyle adjustments and nutritional choices?

 

For readers actively searching for answers, the challenge isn’t a lack of options — it’s too many conflicting claims. Some products promise dramatic outcomes. Others lean heavily on scientific jargon without explaining what it actually means for everyday cognitive function. And many leave readers unsure where ingredient research ends and marketing language begins.


 

That gap is exactly where interest in cognitive-support supplements like Synaptigen tends to emerge.

 

Rather than positioning itself as a quick fix, Synaptigen is presented by the company as a daily brain-support formula designed to help maintain memory, focus, and mental clarity over time. The brand’s messaging emphasizes support, nourishment, and long-term cognitive maintenance — concepts that resonate with people who want to stay proactive about brain health without jumping to extreme solutions.

 

What Is Synaptigen? A Brand-Positioned Overview


 

Synaptigen is a dietary supplement marketed by its manufacturer as a daily cognitive support formula intended to help maintain memory, focus, and overall mental clarity as part of a long-term wellness routine.

 

According to the company, Synaptigen is designed for adults who are interested in supporting normal brain function through nutrition rather than relying solely on stimulants or short-term cognitive enhancers. The product is positioned around the idea that brain health, like physical health, benefits from consistent nutritional support over time, especially as natural changes occur with age.

 

The brand states that Synaptigen’s formula combines probiotics, prebiotics, and plant-derived nutrients in a single, easy-to-use tablet. Rather than focusing on immediate stimulation, the company frames its approach around supporting the internal environment in which brain cells function, with an emphasis on nourishment and maintenance.


 

Importantly, Synaptigen is presented as a dietary supplement, not a medication. The company does not describe it as a treatment, therapy, or cure for any medical condition. Instead, it is intended to complement healthy lifestyle habits such as balanced nutrition, adequate sleep, physical activity, and stress management.

 

From a formulation standpoint, the brand highlights several characteristics that may appeal to certain consumers, including:

 

  • Natural, non-GMO ingredients, according to the company
  • No added stimulants, which may be relevant for individuals sensitive to caffeine or similar compounds
  • A once-daily, melt-in-the-mouth tablet, designed for convenience and ease of use

 

As with any supplement, whether Synaptigen is an appropriate choice depends on individual needs, expectations, and health considerations. Understanding how the company says the formula is structured — and how its ingredients are intended to play a role — is a necessary next step before evaluating fit.


 

A Closer Look at the Ingredients in Synaptigen

 

To evaluate any cognitive support supplement responsibly, it’s important to separate ingredient research from product-level claims. What follows is a high-level overview of the individual ingredients listed by the company, along with context on how these ingredients are generally discussed in scientific and nutritional literature.

 

This section is intended for educational purposes only. While certain ingredients have been studied independently, Synaptigen as a finished product has not been clinically studied, and outcomes can vary from person to person.


 

Probiotic Strains

 

According to the company, Synaptigen includes several probiotic strains selected for their potential role in supporting gut health, which some research suggests may be connected to broader neurological and cognitive processes through the gut–brain axis.

 

Lactobacillus paracasei

 

This probiotic strain is commonly studied for its role in digestive balance and immune system interaction. In ingredient-level research, Lactobacillus paracasei has been explored for how gut microbiota may influence inflammation and metabolic signaling — factors that researchers believe can indirectly affect overall brain function.

 

Lactobacillus reuteri

 

Lactobacillus reuteri is another well-researched probiotic strain. Ingredient studies often examine its role in maintaining gut lining integrity and supporting balanced microbial populations. Some researchers have investigated how these functions may contribute to general neurological signaling through gut–brain communication pathways, though these effects are not specific to any single supplement.

 

Bifidobacterium lactis BL-04

 

This strain is frequently included in probiotic formulations and is typically studied for immune support and digestive comfort. Ingredient-level literature suggests that balanced gut bacteria may play a role in how the body manages stress responses and inflammatory markers, which are areas of interest in broader cognitive health research.

 

Prebiotic Support

 

Inulin

 

Inulin is a naturally occurring prebiotic fiber that serves as a food source for beneficial gut bacteria. Research at the ingredient level shows that prebiotics like inulin can help support the growth and activity of probiotics, potentially enhancing their ability to contribute to overall gut balance. A healthier gut environment is often discussed in research as one factor that may influence mental clarity and overall wellness.

 

Mineral and Plant-Based Components

 

Tricalcium Phosphate

 

Tricalcium phosphate is commonly used in supplements as a source of calcium and as a stabilizing or anti-caking agent. Calcium plays a recognized role in normal nerve signaling and cellular communication, though its inclusion in supplements is generally intended to support overall nutritional balance rather than produce targeted cognitive effects.

 

Strawberry Extract

 

Plant extracts like strawberry extract are often included for their naturally occurring phytonutrients and antioxidant compounds. Ingredient research into berries frequently focuses on how antioxidants may help protect cells from oxidative stress, a process that is widely studied in relation to aging and general brain health.

 

Peppermint Extract

 

Peppermint extract is traditionally associated with digestive comfort and sensory alertness. Some ingredient-level studies explore peppermint’s aromatic and phytochemical properties in relation to mental alertness and perceived clarity, although effects can be subjective and vary between individuals.

 

Important Context for Readers

 

While each of these ingredients has been studied individually in different contexts, it’s important to emphasize that ingredient research does not automatically translate to product-specific outcomes. The way ingredients interact within a proprietary blend, individual biology, dosage, and consistency of use all influence how a supplement may be experienced.

 

This is why responsible evaluation goes beyond ingredient lists alone. Understanding how the brand positions the overall formula, how it is intended to be used, and who it may or may not be appropriate for is just as important as reviewing the components themselves.

 

Read More: Gut-Brain Probiotic Supplement for Digestive Comfort, Mental Clarity, and Long-Term Wellness

 

How Synaptigen Is Designed to Be Used

 

According to the company, Synaptigen is intended to be used as a once-daily cognitive support supplement, incorporated into a consistent wellness routine rather than taken on an as-needed basis.

 

Daily Use Format

 

Synaptigen comes in a melt-in-the-mouth tablet, which the brand states can either be allowed to dissolve slowly or gently chewed. This delivery format is positioned as a convenience feature, particularly for individuals who prefer not to swallow traditional capsules.

 

Per the official website, the recommended usage is:

 

  • One tablet per day
  • Taken consistently as part of a daily routine

 

The company does not promote Synaptigen as a stimulant or quick-acting cognitive enhancer. Instead, it is framed as a supplement designed to support ongoing cognitive maintenance over time when used regularly.

 

Setting Realistic Expectations

 

One of the most important considerations with any dietary supplement is understanding what it is — and what it is not.

 

Synaptigen is not positioned as a medication, treatment, or therapy for cognitive conditions. The brand does not state that it diagnoses, treats, cures, or prevents any disease. Rather, it is presented as a nutritional option for adults who want to be proactive about supporting memory, focus, and mental clarity as part of a broader lifestyle approach.

 

As with most supplements, individual experiences may vary based on factors such as:

 

  • Age and baseline cognitive health
  • Diet and nutrient status
  • Sleep quality and stress levels
  • Consistency of use
  • Medications or underlying health conditions

 

For this reason, the company emphasizes ongoing use rather than immediate or dramatic effects. Readers evaluating Synaptigen may want to think in terms of gradual support and maintenance, not instant changes.

 

Who This Usage Style May Appeal To

 

The simplicity of a once-daily tablet may be appealing to people who:

 

  • Prefer low-effort routines
  • Want to avoid caffeine or stimulant-based products
  • Are looking for a supplement that fits into long-term wellness habits rather than short-term performance goals

 

At the same time, individuals seeking rapid or noticeable cognitive effects in the short term may find that a daily support supplement does not align with their expectations.

 

Who Synaptigen May Be Right For

 

Choosing a cognitive support supplement is a personal decision, and no single product is an ideal fit for everyone. Rather than relying on testimonials or generalized claims, a self-assessment approach can help readers decide whether Synaptigen aligns with their needs and expectations.

 

Synaptigen May Align Well With People Who:

 

  • Are looking to support memory and focus as part of long-term wellness: Individuals who view cognitive health as something to maintain gradually — similar to physical fitness — may appreciate a supplement positioned around daily nutritional support rather than quick stimulation.
  • Prefer non-stimulant cognitive support options: According to the company, Synaptigen does not contain added stimulants. This may be relevant for people who are sensitive to caffeine or prefer to avoid products that can interfere with sleep or cause jitteriness.
  • Value gut-health-oriented approaches to overall wellness: Readers interested in the gut–brain connection and the potential role of probiotics and prebiotics in broader wellness routines may find the formulation concept aligns with their interests.
  • Want a simple, once-daily routine: The melt-in-the-mouth tablet format and once-per-day usage may appeal to those who prefer minimal complexity in their supplement regimen.

 

Other Options May Be Preferable For People Who:

 

  • Are seeking rapid or dramatic cognitive changes: Synaptigen is not positioned as a fast-acting or performance-enhancing product. Individuals looking for immediate or highly noticeable effects may want to explore other approaches with their healthcare provider.
  • Have diagnosed cognitive or neurological conditions: People managing medical conditions related to memory or cognition should consult a qualified healthcare professional before considering any supplement, as Synaptigen is not intended to diagnose, treat, or manage disease.
  • Prefer products with clinically studied finished formulations: While individual ingredients have been researched, Synaptigen as a complete product has not been clinically studied. Readers who prioritize finished-product clinical trials may wish to factor this into their decision.

 

Questions to Ask Yourself Before Deciding

 

  • Am I looking for ongoing support rather than a quick solution?
  • Do I understand the difference between ingredient research and product-specific evidence?
  • Am I willing to use a supplement consistently as part of a broader lifestyle approach?

 

Taking the time to answer these questions honestly can help clarify whether Synaptigen fits your expectations — or whether another approach might be more appropriate.

 

Synaptigen Pricing, Bundles, and What the Company Offers

 

Pricing transparency is an important part of evaluating any dietary supplement, especially in high-YMYL categories like cognitive health. All pricing and bundle information below is attributed to the company’s official website and reflects how Synaptigen is presented to consumers at the time of publication.

 

Available Purchase Options

 

According to the company, Synaptigen is sold in multi-bottle packages, with pricing structured to encourage longer-term use rather than single short trials. The brand states that the following options are typically available:

 

  • Smaller multi-bottle option: Priced at $79 per bottle, positioned for those who want to try the product before committing to longer-term use.
  • Mid-range bundle: Priced at $69 per bottle, often presented as a balance between upfront cost and longer usage.
  • Best-value bundle: Priced at $49 per bottle, offered with a larger quantity and positioned by the company as its recommended option for extended use.

 

The company emphasizes that pricing is per bottle, and total order cost depends on the bundle selected at checkout. Readers are encouraged to review current pricing directly on the official website, as promotions and availability may change.

 

For readers who want to verify current bundle options or see what is currently available, Synaptigen can be found through the company’s official checkout page.

 

Bonuses and Shipping 

 

Per the official website, larger bundle purchases may include digital bonus materials at no additional charge. These bonuses are informational guides focused on topics such as sleep habits, learning strategies, and memory techniques. The company presents these as educational resources rather than medical programs.

 

The brand also states that:

 

  • Free shipping is typically offered on larger orders within the United States
  • International shipping is available for select regions, with additional fees and longer delivery times

 

Shipping timelines and fees vary by location and are displayed during checkout.

 

Refund Policy Overview

 

According to the company, Synaptigen purchases are covered by a 180-day refund policy. The brand states that customers who are not satisfied may request a refund within this period by returning their order in accordance with the company’s published refund instructions.

 

As with any purchase, readers are encouraged to review the full refund and return policy directly on the official website to understand all requirements and conditions before ordering.

 

Pricing Disclaimer: All prices and offers were accurate at the time of writing (December 2025) and are subject to change at the company’s discretion.

 

Included Bonus Materials: What the Company Says Is Offered

 

In addition to the supplement itself, the company states that certain Synaptigen bundle options may include digital educational materials provided at no additional charge. These bonuses are presented as general informational guides rather than medical or therapeutic programs.

 

Bonus #1: Deep Sleep Blueprint

 

According to the company, this digital guide focuses on sleep-related habits and routines intended to support better rest. The material is described as covering topics such as:

 

  • Environmental adjustments related to sleep comfort
  • Common lifestyle habits that may influence sleep quality
  • General relaxation and wind-down techniques

 

This guide is positioned as educational content, not as a treatment for sleep disorders or medical conditions.

 

Bonus #2: Sharp Mind in 7 Days

 

The company describes this bonus as an informational resource that explores learning techniques and mental habits. Topics are said to include:

 

  • Memory and recall strategies used in educational contexts
  • Simple cognitive exercises designed to encourage mental engagement
  • Everyday practices that may support mental clarity

 

Despite the title, this guide is not presented as a guarantee of results within a specific timeframe. Individual experiences with educational strategies can vary widely.

 

Bonus #3: 10 Proven Ways to Learn Faster and Boost Memory

 

Per the official website, this bonus focuses on learning and memory techniques commonly discussed in cognitive psychology and educational research. The material is described as highlighting:

 

  • Mnemonics and associative learning concepts
  • Visualization-based memory strategies
  • Habit-based approaches to skill and knowledge retention

 

As with the other bonuses, this guide is informational in nature and does not replace professional educational or medical advice.

 

Important Context About Bonuses

 

It’s important for readers to understand that:

 

  • These bonuses are digital informational resources, not supplements or medical programs
  • They are provided at the company’s discretion and may change over time
  • Access is typically delivered electronically following purchase

 

While some readers may find these materials helpful as part of a broader learning or wellness routine, they should not be interpreted as diagnostic, therapeutic, or outcome-based tools.

 

Frequently Asked Questions About Synaptigen

 

How does Synaptigen work, according to the company?

 

According to the company, Synaptigen is designed as a daily dietary supplement that supports memory, focus, and mental clarity through a combination of probiotics, prebiotics, and plant-derived nutrients. The brand frames its approach around supporting internal systems that are involved in normal brain function rather than providing stimulation or acting as a treatment for any condition.

 

Any references to how the product is “designed to work” reflect the company’s intended formulation philosophy and should not be interpreted as guaranteed outcomes.

 

Is Synaptigen a medication or medical treatment?

 

No. Synaptigen is marketed as a dietary supplement, not a medication. The company does not position it as a treatment, therapy, or cure for any disease or medical condition. Individuals with health concerns related to cognition should consult a qualified healthcare professional before using any supplement.

 

How do I take Synaptigen?

 

Per the official website, Synaptigen is taken once per day in the form of a melt-in-the-mouth tablet. The tablet can be allowed to dissolve slowly or gently chewed. Consistent daily use is emphasized by the company as part of a long-term wellness routine.

 

How long does it take to notice changes?

 

The company does not provide a specific timeline for when individuals may notice changes. As with most dietary supplements, individual experiences can vary based on factors such as age, diet, lifestyle, and consistency of use. Readers are encouraged to approach Synaptigen with realistic expectations and to avoid assuming immediate effects.

 

Does Synaptigen contain stimulants?

 

According to the company, Synaptigen does not contain added stimulants. This may be relevant for individuals who prefer cognitive support options that do not rely on caffeine or similar compounds.

 

Is Synaptigen a subscription or recurring charge?

 

The company states that Synaptigen is offered as a one-time purchase, not an automatic subscription. Customers are encouraged to review checkout details carefully to confirm current purchase terms before completing an order.

 

What is the refund policy?

 

According to the company, Synaptigen purchases are covered by a 180-day refund policy, subject to the brand’s published return requirements. Readers should review the full refund policy on the official website to understand eligibility, timelines, and return procedures.

 

Where can I purchase Synaptigen?

 

Synaptigen is sold directly through the company’s official website. For those who want to review current offers or verify availability, the product can be accessed through the official Synaptigen ordering page.

 

Final Verdict: A Measured Look at Synaptigen

 

Synaptigen is positioned by its manufacturer as a daily cognitive support supplement intended for adults who want to take a proactive, nutrition-based approach to maintaining memory, focus, and mental clarity over time.

 

Rather than emphasizing stimulation or rapid effects, the company frames Synaptigen around long-term support and consistency, using a blend of probiotics, prebiotics, and plant-derived ingredients. This approach may appeal to individuals who are interested in the broader concept of gut–brain balance and who prefer supplements that fit into everyday wellness routines without added stimulants.

 

At the same time, it’s important to recognize the limitations that come with any dietary supplement. While individual ingredients included in Synaptigen have been studied in various contexts, the product itself has not been clinically evaluated as a finished formulation, and individual experiences can vary significantly. Synaptigen is not intended to diagnose, treat, cure, or prevent disease, and it should not be viewed as a substitute for medical care.

 

From a practical standpoint, the once-daily tablet format, non-stimulant positioning, and availability of longer-term bundle options may be appealing for certain users. Others — particularly those seeking immediate cognitive changes or products backed by finished-product clinical trials — may find that alternative approaches are more appropriate.

 

Ultimately, Synaptigen appears best suited for readers who:

 

  • Understand the difference between ingredient research and product-specific evidence
  • Are comfortable with gradual, maintenance-oriented support
  • Want a supplement that complements broader lifestyle habits rather than replaces them

 

As with any wellness decision, reviewing the full product details, policies, and ingredient information directly with the company — and consulting a healthcare professional when appropriate — can help ensure that expectations align with reality.

 

For readers who wish to explore current offers or review the company’s full disclosures, Synaptigen is available through the official website.

 

Contact Information (Company-Provided)

 

For product-specific questions, shipping inquiries, or refund requests, the company lists the following contact details:

  

Important Disclaimers and Disclosures

 

  • FDA Health Disclaimer: These statements have not been evaluated by the Food and Drug Administration. Synaptigen is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.
  • Professional Medical Disclaimer: The information provided in this article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
  • Ingredient Research Disclosure: Research discussed in this article relates to individual ingredients only. Synaptigen, as a finished product, has not been clinically studied. Outcomes may vary depending on individual health factors, consistency of use, and lifestyle variables.
  • Results May Vary: Individual experiences with dietary supplements can vary significantly based on age, baseline health, diet, genetics, medications, and other factors. No specific results are guaranteed.
  • Affiliate Disclosure: This article contains affiliate links. If you choose to make a purchase through these links, a commission may be earned at no additional cost to you. This helps support independent research and editorial efforts.
  • Pricing Disclaimer: All pricing, bundle offers, and promotional details were accurate at the time of publication (December 2025) and are subject to change. Always verify current pricing and policies directly on the company’s official website.

   



Source link

19 12, 2025

XRP Price Prediction: XRP Flashes Oversold Reversal Signals as RSI Drops to 33 and Key Support Holds

By |2025-12-19T00:01:24+02:00December 19, 2025|Crypto News, News|0 Comments

XRP is back in focus as mounting selling pressure pushes key momentum indicators into oversold territory, raising fresh debate over whether the market is nearing a short-term turning point.

XRP is drawing renewed attention from market participants as market structure and momentum metrics indicate the asset may be approaching a critical inflection point. After a steady decline over the past week, XRP is trading near $1.88, reflecting a 1.41% daily drop, while maintaining strong liquidity with more than $3.5 billion in 24-hour trading volume.

XRP RSI Hits Oversold Territory as Price Tests Key Support

Crypto analyst Good Evening Crypto (@AbsGMCrypto) highlighted the oversold condition in a recent post, stating, “BREAKING: $XRP WEEKLY RSI HITS 33! Could see a large bounce from these ranges…”

XRP weekly RSI hits 33, signaling a potential bounce from oversold levels. Source: @AbsGMCrypto via X

According to commonly observed TradingView market data trends, similar weekly RSI levels have marked key turning points during prior cycles. During the 2017–2018 bull run, XRP advanced from approximately $0.20 to $3.40 after extended periods of oversold conditions. A comparable setup appeared in November 2024, when subdued momentum preceded a 580% rally that peaked in early 2025.

While historical patterns can provide context, they do not guarantee similar outcomes. Nevertheless, the recurrence of these signals has kept XRP under close observation among technically focused traders.

Analysts Identify $1.83–$1.90 as a Crucial XRP Support Zone

Short-term market behavior indicates XRP is attempting to stabilize above a well-defined technical area. The asset recently dipped into the $1.83–$1.87 range, a zone that has attracted consistent buying interest in recent sessions.

XRP Price Prediction: XRP Flashes Oversold Reversal Signals as RSI Drops to 33 and Key Support Holds

XRP shows a bullish reaction from key support, with momentum favoring an upside move toward near-term technical targets. Source: ExpertTraderASK on TradingView

TradingView analyst ExpertTraderASK described the setup as constructive on lower timeframes: “Price is showing a strong bullish reaction from a critical support zone; momentum favors the upside on the 15M timeframe.”

The analyst outlined near-term technical targets at $1.8830, $1.8990, and $1.9230, while emphasizing the importance of disciplined position sizing and stop-loss management. This intraday optimism contrasts with higher-timeframe structures that continue to point toward consolidation rather than a confirmed trend reversal.

Long-Term Chart Signals Mixed Outlook for XRP

From a broader perspective, crypto strategist EGRAG CRYPTO (@egragcrypto) shared a long-term weekly chart showing XRP trading within a multi-year descending triangle that has been developing since the 2018 peak. The descending resistance trendline, referred to as the “Line of Hestia,” continues to limit upside attempts.

Long-Term Chart Signals Mixed Outlook for XRP

XRP tests key support inside a long-term descending triangle, capped by the “Line of Hestia” resistance. Source: @egragcrypto via X

The chart suggests XRP is once again testing triangle support, an area where historical probability models often favor upward resolution. According to technical pattern studies, descending triangles resolve to the upside approximately 70% of the time, although the projected resolution window in this case extends as far as 2027, drawing skepticism from parts of the trading community.

This longer-term structure highlights the contrast between short-term momentum signals and broader cyclical consolidation, underscoring the complexity of XRP’s current market position.

Final Thoughts

XRP currently sits at a pivotal juncture, where short-term technical signals suggest potential stabilization, yet broader market structure continues to warrant caution. Holding the $1.83–$1.90 support zone remains critical, as sustained defense could open the door to a modest recovery, while a breakdown may invite further downside pressure.

Final Thoughts

XRP was trading at around 1.87, down 1.41% in the last 24 hours at press time. Source: XRP price via Brave New Coin

As momentum indicators, volume trends, and overall market sentiment evolve, traders are advised to remain patient and disciplined. While oversold conditions may offer tactical opportunities, unresolved risks underscore the importance of prudent risk management. These insights reflect prevailing market dynamics and do not constitute investment advice.

Source link

18 12, 2025

XAU/USD Holds Near $4,330 as Softer U.S. CPI Revives Fed-Cut Bets

By |2025-12-18T22:47:38+02:00December 18, 2025|Forex News, News|0 Comments


Gold prices are consolidating near record territory on Thursday, December 18, 2025, as traders juggle two powerful forces pulling in opposite directions: a still-resilient U.S. dollar and the renewed case for lower U.S. interest rates after a cooler-than-expected inflation reading.

In early trading, spot gold was around the $4,330-per-ounce area, modestly lower on the day after a strong prior-session move, while U.S. gold futures were also fractionally softer. [1]

But the bigger story for bullion today is macro: U.S. CPI cooled to 2.7% year-on-year in November, under the 3.1% consensus forecast in a Reuters poll—fuel for the “rates can fall further” narrative that has helped propel gold’s historic 2025 rally. [2]


Gold price snapshot around today’s 09:55 update

Gold’s headline price action on Dec. 18 is best described as steady-to-soft, not a collapse—more like a market taking a breath near all-time highs after an extraordinary year.

  • Spot gold: roughly $4,330/oz (slightly down on the session) [3]
  • U.S. gold futures: roughly $4,360/oz (also slightly lower) [4]

A later read from Reuters showed spot gold down 0.4% to $4,323.57/oz (as of 12:10 GMT) with U.S. futures down 0.4% to $4,356.10, underscoring the day’s “small dip” tone rather than any trend break. [5]

Investing.com, meanwhile, cited spot gold at $4,336.54/oz at 09:15 ET (14:15 GMT), with February gold futures at $4,370.30/oz—again consistent with a narrow, high-level range. [6]


What’s driving gold today: dollar strength vs. rate-cut optimism

1) The U.S. dollar was a near-term headwind—until CPI hit

One of the simplest relationships in commodities is also one of the most reliable: a stronger dollar can pressure gold, because it makes dollar-priced bullion more expensive for overseas buyers.

Reuters noted the dollar index edged up after touching a near one-week high the prior session, a factor weighing on gold as traders positioned cautiously ahead of inflation data. [7]

But CPI shifted the balance.

After the data, Reuters reported the dollar index weakened (down 0.12% to 98.25 in that update) and Treasury yields fell, an environment that typically improves gold’s appeal. [8]

2) U.S. inflation surprised lower: CPI 2.7% vs. 3.1% expected

The headline macro catalyst today is the CPI undershoot:

  • Headline CPI:+2.7% YoY in November
  • Core CPI (ex food & energy):+2.6% YoY
  • Consensus forecast:+3.1% YoY for headline CPI (Reuters poll) [9]

There’s an important nuance: Reuters reported the CPI release was affected by a 43-day government shutdown, and the Bureau of Labor Statistics did not publish month-to-month CPI changes because October data collection was disrupted. That “data quality caveat” is a big reason why markets may be hesitant to chase gold aggressively higher on a single print. [10]

Even so, softer inflation tends to push investors toward the view that real yields can fall, which is a structural positive for non-yielding assets like gold. [11]


The Fed narrative: rate cuts, politics, and the next chair question

Gold’s 2025 surge has been tightly linked to the belief that the U.S. is in, or nearing, a lower-rate regime. Today’s flow of Fed-related headlines reinforced that debate.

Reuters highlighted that:

  • Markets were pricing two additional 25-basis-point rate cuts next year in the update it cited. [12]
  • Fed Governor Christopher Waller said the central bank still has room to cut amid rising job market weakness. [13]
  • U.S. President Donald Trump said the next Fed chair will be someone who believes in lower interest rates “by a lot,” and that a successor to Fed Chair Jerome Powell would be announced early next year. [14]

For bullion investors, this mix matters because gold can react to two things at once:

  1. Actual policy expectations (rate cuts = supportive), and
  2. Perceived institutional risk (concerns about independence or political pressure can support safe-haven demand).

Reuters’ broader gold-forecast reporting this week explicitly included worries about Fed independence among the factors analysts see supporting bullion into 2026. [15]


Central bank day in Europe adds context: BoE cuts, ECB holds, BoJ next

Dec. 18 isn’t only about the Fed. It’s also a heavyweight central-bank week globally, and those decisions feed into FX and bond-market moves that spill over into gold.

Investing.com reported:

  • The Bank of England cut rates by 25 bps
  • The European Central Bank held rates steady
  • The Bank of Japan decision is due Friday, with markets widely pricing a 25 bps hike [16]

That mix matters for gold in two ways:

  1. Currency channels: The more global central banks diverge, the more volatile FX can become—often boosting demand for hard assets as portfolio stabilizers.
  2. Global real-rate expectations: If major central banks lean easier (or if easing cycles broaden), it can reinforce the long-run case for holding gold.

Silver, platinum, palladium: the broader precious-metals complex is still “hot”

Gold isn’t moving in isolation. On Dec. 18, Reuters and Investing.com both highlighted unusual strength across precious metals:

  • Silver hovered close to its record highs after a huge year-to-date surge, supported by industrial demand and a supply deficit. [17]
  • Reuters cited silver’s record high at $66.88/oz in the prior session and noted the metal had risen ~129% year-to-date in that report. [18]
  • Platinum and palladium also pushed to multi-year highs in Reuters’ update, reflecting a broad “metals bid,” not just a gold-only trade. [19]

Why this matters for gold: when the whole complex runs together, positioning risk rises—profit-taking in one metal can spill into others, even if gold’s fundamentals remain bullish.


Regional news that matters: Thailand targets gold-trade flows, Australia posts a “gold bonanza”

Thailand: central bank calls for tighter gold-trade controls

One of today’s most striking region-specific stories comes from Thailand, where policymakers are explicitly linking gold trading to currency-market stress.

Reuters reported the Thai central bank is urging the finance ministry to regulate gold trading after a surge in transactions helped push the baht higher, with the governor saying that on days of sharp baht strength, gold transactions can account for about half of the flows driving the move. [20]

For global gold readers, the takeaway is bigger than Thailand: it’s a real-time example of how active gold trading and cross-border flows can become macro-relevant, affecting currencies, policy debates, and potentially even local market access and liquidity.

Australia: higher export earnings, gold becomes a top-tier export

Australia’s government-linked commodity outlook also underscored how gold’s high price level is reshaping the real economy.

Reuters reported Australia revised expected resource export earnings up 4% to A$383 billion for the current financial year, pointing to record gold prices as a key contributor. It also said gold is set to become Australia’s second most valuable resource export (after iron ore) in the 2025–26 financial year. [21]

Notably, that report included a forward-looking anchor: it said gold prices are likely to remain strong at around $4,000/oz over 2026 before falling in 2027 (in that outlook). [22]

That matters for the “forecast” question investors keep asking: even more cautious government-linked assumptions are now using $4,000 gold as a baseline for next year—a remarkable reset compared with the pre-2024 era.


Gold forecast 2026: why $5,000 is on the table—and why the rally could cool

A day before today’s CPI-driven headlines, Reuters published one of the most comprehensive roundups of the market’s 2026 gold forecasts—and the range is wide.

Key points from that Reuters analysis:

  • Gold is up ~64% in 2025 and hit a record $4,381/oz in October. [23]
  • Analysts at JPMorgan, Bank of America, and Metals Focus see bullion reaching $5,000/oz in 2026. [24]
  • Morgan Stanley forecast gold at $4,500/oz by mid-2026, while JPMorgan projected averages above $4,600 in Q2 and more than $5,000 in Q4, and Metals Focus saw $5,000 by end-2026. [25]
  • More conservative, Macquarie projected an average of $4,225 in 2026, describing a world that may “stabilise a bit,” with growth improving and real rates staying relatively high. [26]

The structural pillars bulls keep citing

The same Reuters report laid out why strategists believe this cycle has different “supports” than older gold booms:

  • Central-bank reserve diversification is expected (for a fifth consecutive year) to underpin demand. [27]
  • JPMorgan’s metals strategy team estimated that to keep prices flat, quarterly central bank + investment demand of about 350 metric tons is needed—and forecast buying could average 585 tons per quarter in 2026. [28]
  • Investor gold holdings as a share of total assets under management rose to 2.8% from pre-2022 levels of 1.5% (per JPMorgan’s commentary in that report), indicating a bigger strategic allocation pool than in prior cycles. [29]

The risks: corrections, forced selling, and “bubble” talk

Even in a bullish framework, the risks are real:

  • Reuters reported the BIS warned this month that gold and share prices soaring together is a phenomenon not seen in at least half a century, raising questions about potential bubbles. [30]
  • Analysts noted that sharp equity drawdowns can sometimes force liquidation of even safe-haven holdings—meaning gold can dip in a broader de-risking event. [31]
  • The same Reuters piece flagged that jewelry demand fell 23% in Q3, and that central bank purchases and ETF inflows could slow in 2026—implying the rally may persist, but with less explosive momentum. [32]

Analysis: why gold is “pausing” today, not reversing

Thursday’s price action fits a common late-cycle pattern in strong bull markets:

  1. Macro news turns favorable (cooler CPI, more rate-cut odds)
  2. Gold does not instantly surge because traders had already positioned for the theme—or because they’re waiting for confirmation amid data noise
  3. The market consolidates at a high level, letting other metals (silver/platinum) absorb more of the speculative heat

Investing.com explicitly described profit-taking after a sharp rally over the past week, while still pointing to “structural support” from central-bank buying and de-dollarisation themes. [33]

And Reuters captured the same cautious tone ahead of CPI, quoting UBS strategist Giovanni Staunovo on investors preferring not to head into the inflation report with open risk. [34]


What to watch next for the gold price

Gold’s next decisive move is likely to come from a combination of policy confirmation and liquidity:

  • December inflation data (released mid-January): Reuters noted some strategists see the November CPI as unusually noisy because of shutdown-related collection issues—making the next CPI prints critical for rate-cut conviction. [35]
  • Fed January meeting expectations: The market is already debating how soon cuts resume, and CPI has nudged that conversation. [36]
  • Bank of Japan decision Friday: If the BoJ surprises, it can drive yen moves and global bond-market repricing, with knock-on effects for gold. [37]
  • Whether the dollar trend breaks: Today’s post-CPI dip in the dollar index matters if it becomes persistent rather than a one-session reaction. [38]

Bottom line: Gold’s 2025 bull market remains intact—and the 2026 debate is now about “how high,” not “whether”

As of today’s 09:55 update on December 18, 2025, gold remains firmly parked near the $4,330/oz region, reflecting a market that is digesting softer U.S. inflation while still respecting short-term dollar strength and profit-taking near records. [39]

The most important shift in today’s news flow is not the day’s small price dip. It’s the macro narrative reset: with CPI at 2.7% YoY versus 3.1% expected, the case for further easing in 2026 looks stronger—exactly the environment where gold has historically done well. [40]

And with major banks now openly discussing $4,500 to $5,000 gold scenarios in 2026—alongside more conservative forecasts that still sit above $4,200—the metal enters year-end not as a fringe hedge, but as a core macro asset class that’s forcing governments, central banks, and investors to adapt. [41]

XAUUSD Gold Technical Analysis Levels Revealed

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.reuters.com, 5. www.reuters.com, 6. ng.investing.com, 7. www.reuters.com, 8. www.reuters.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.reuters.com, 12. www.reuters.com, 13. www.reuters.com, 14. www.reuters.com, 15. www.reuters.com, 16. ng.investing.com, 17. www.reuters.com, 18. www.reuters.com, 19. www.reuters.com, 20. www.reuters.com, 21. www.reuters.com, 22. www.reuters.com, 23. www.reuters.com, 24. www.reuters.com, 25. www.reuters.com, 26. www.reuters.com, 27. www.reuters.com, 28. www.reuters.com, 29. www.reuters.com, 30. www.reuters.com, 31. www.reuters.com, 32. www.reuters.com, 33. ng.investing.com, 34. www.reuters.com, 35. www.reuters.com, 36. www.reuters.com, 37. ng.investing.com, 38. www.reuters.com, 39. www.reuters.com, 40. www.reuters.com, 41. www.reuters.com



Source link

18 12, 2025

EUR/USD Analysis Today 18/12: Future Fed Policies (Chart)

By |2025-12-18T22:15:37+02:00December 18, 2025|Forex News, News|0 Comments

EUR/USD Analysis Summary Today

  • Overall Trend: : Upward Technical Correction
  • Support Levels for EUR/USD Today: 1.1700 – 1.1650 – 1.1570.
  • Resistance Levels for EUR/USD Today: : 1.1800 – 1.1880 – 1.1940.

EUR/USD Trading Signals:

  • Buy EUR/USD from the support level of 1.1640 with a target of 1.1820 and a stop-loss at 1.1570.
  • Sell EUR/USD from the resistance level of 1.1810 with a target of 1.1500 and a stop-loss at 1.1900.

Technical Analysis of EUR/USD Today:

Amidst an upward technical correction, the EUR/USD pair jumped to its highest level in two months, briefly testing the psychological resistance level of 1.1800. This followed a widely expected US Federal Reserve interest rate cut, which simultaneously revealed deep internal divisions within the bank. Markets interpreted the split vote and Jerome Powell’s data-dependent remarks as bearish for the US Dollar against other major currencies, providing support for the Euro. Focus is now shifting to the Fed’s path for 2026 and the uncertainty surrounding the selection of Powell’s successor.

For his part, US Federal Reserve Chairman Jerome Powell emphasized the difficulty of formulating monetary policy in the face of high inflation and weak job prospects. He insisted that monetary policy would be data-driven. According to the latest updates, the median forecast points to a further rate cut in 2026, although there is considerable variation in expectations.

Overall, Fed policy will remain a core factor in 2026, especially as Powell’s term ends in May, adding to the climate of uncertainty.

EUR/USD levels confirm the upward trend.

According to reliable trading platforms and based on the daily chart, technical indicators support an upward technical correction for the EUR/USD pair. As previously mentioned, breaking the psychological resistance level of 1.1800 will be crucial for strengthening the bulls’ control and preparing for significant upward breakouts, followed by the psychological peak of 1.2000, the most prominent target for the EUR/USD in the new year. Currently, the 14-day Relative Strength Index (RSI) is near the overbought level of 70, and unless it gains new positive momentum, expect profit-taking. Simultaneously, the MACD indicator has crossed into overbought territory.

The Bearish Scenario: For the pair to return to a downward trajectory on the daily timeframe, it would require a retreat back toward the 1.1500 support level. The EUR/USD pair will be influenced today by the European Central Bank’s policy announcement, with expectations that interest rates will remain unchanged. The bank’s announcement will be at 3:15 PM Egypt time, followed by a statement from ECB President Lagarde at 3:45 PM Egypt time. On the US side, the focus will be on the weekly US jobless claims report and the Philadelphia Fed Manufacturing Index, both due at 3:30 PM Egypt time.

Trading Advice:

Be cautious. If the EUR/USD fails to break above the 1.1800 level, profit-taking may begin. Never take unnecessary risks.

EUR/USD Forecast for 2026

According to forex trading experts, Scotiabank predicts that the EUR/USD exchange rate will rise to the 1.22 resistance level by the end of 2026, with a further increase to 1.24 the following year. In the same vein, Société Générale sees the possibility of the euro/dollar exchange rate rising to the psychological resistance level of 1.20 by early 2026, but expects a gradual decline to 1.14 by the end of 2026.

Mizuho also predicted that the EUR/USD exchange rate would reach the resistance level of 1.22 by the end of 2026, noting that “Federal Reserve cuts, German fiscal spending, and increased hedging against US dollar exchange rate risks will lead to a repeat of the 2017 scenario in 2025 and 2026, but it is difficult to predict beyond that.”

Ready to trade our Forex daily forecast? We’ve shortlisted the top forex brokers in the industry for you.

Source link

18 12, 2025

The #1 Tea for Boosting Your Mood, According to a Dietitian

By |2025-12-18T22:06:34+02:00December 18, 2025|Dietary Supplements News, News|0 Comments


Key Takeaways

  • Green tea is a top mood booster. Its amino acids (l-theanine and arginine) and antioxidants (like EGCG) support brain and gut health, reduce inflammation, and may help improve mood and lower anxiety.
  • Peppermint, chamomile, and lavender teas can lift your mood, promote relaxation, and reduce stress, making them ideal for evening routines.
  • The ritual matters as much as the tea. Simply brewing and sipping a warm cup provides hydration, a soothing sensory experience, and a mental reset that can improve overall well-being.

When a bad mood strikes—or when you’ve been in a slump for a few days—it’s easy to fall back on less-than-healthy habits, whether that’s scrolling, reaching for indulgent snacks, or being sassy towards loved ones. However, there are plenty of healthier activities, foods, and beverages that can help turn your bad mood on its head—and one of them is simply brewing a warm cup of tea. “The act of making tea can be as beneficial as the tea itself,” says Rachelle Robinett, registered herbalist and author of Naturally, The Herbalist’s Guide to Health and Transformation. That said, the type of tea in your mug can have positive impacts on your mood, too.

While there are several mood-boosting teas to choose from, some stand out above the rest for their accessibility and research backing. Here we’ll tease out one of the best (and a few runners-up), so the next time you’re feeling grumpy, you can reach for a warm cup of tea to elevate your mood.

The Best Mood-Boosting Tea

But of all the tea varieties, which is the best for mood-boosting? While several will help you turn that frown upside down, green tea ranks high on the list. “Green tea is a great option to support your brain health and may even help slow down aging of the brain thanks to the stress-reducing impact of the amino acids l-theanine and arginine,” says Maxine Yeung, RD CPT NBHWC, dietitian and founder of The Wellness Whisk, LLC. “It’s loaded with antioxidant catechins, particularly EGCG (epigallocatechin gallate), which help reduce inflammation, have neuroprotective properties, and are linked with a lower risk for Alzheimer’s and Parkinson’s diseases. Green tea may also have a positive impact on gut microbiota.”

Outside of boosting brain and gut health—inadvertently supporting mood—the high concentration of EGCG in green tea also offers research-backed mood benefits. “Polyphenols, like EGCG, help to raise your mood by influencing mood-related neurotransmitters, reducing inflammation, regulating the stress response, and supporting the gut-brain axis,” Yeung adds.

The amino acid l-theanine in this popular tea has also been shown to reduce symptoms of anxiety and promote feelings of relaxation. “Additionally, some clinical trials have found that bioactive compounds in green tea may improve mood by lowering inflammation and improving sleep quality,” says registered dietitian Kerry Hackworth, MS, RD, LDN. Research has even found the aroma of green tea alone to elicit positive emotions.

However, green tea does contain caffeine, which—while providing an energy boost, potentially benefiting mood in some—isn’t ideal for those sensitive to the stimulant or those needing support during the later hours of the day or night. You can find decaffeinated green tea, but the decaffeination process may reduce its mood-boosting polyphenol content. This is where an herbal tea could be a better choice.

Just one delicious, mood-boosting option is mint—or peppermint—tea. “Mint or peppermint is a caffeine-free and calming bedtime beverage,” Hackworth says. “Mint tea and honey makes an excellent sick-day pick-me-up for me personally.”

Yeung agrees, adding, “I love reaching for mint tea when I need a little pick-me-up. The menthol aroma instantly helps wake me up, clear my mind, and boost my energy.” Research backs this, showing the brain health, relaxation, and anxiety-reduction benefits of mint tea. Robinett and these RDs also mention chamomile and lavender as equally delicious and effective mood-supportive alternatives.

So the next time you’re feeling anxious, down, or irritable, try brewing any one of these teas for a natural and comforting mood boost! While green, mint, chamomile, and lavender are all excellent options, choosing a variety you personally love can boost your mood simply because you enjoy the taste and sensory experience. “It’s worth taking a moment to consider what teas are most enjoyable for us personally,” Robinett suggests.

The Benefits of Drinking Tea for a Better Mood

There are countless varieties of tea—which generally fit into two categories: tea and tisane (better known as herbal tea). “Tea is, as we know, a water-based infusion (or extract) wherein plant-based benefits seep out of herbs and into our cup, and we toss the spent remnants and sip the benefits,” Robinett says. “Technically, though, all tea isn’t tea—only infusions made from the tea plant, Camellia sinensis, are tea; everything else is a tisane.” Common Camellia sinensis teas include black, green, white, red, oolong, and yellow teas—the most popular teas nationwide. Tisane, or herbal tea, is a more unfamiliar territory for many of us, and there are countless herbs that can be brewed into tea.

Regardless of which variety you gravitate towards, tea’s far-reaching health benefits can usually be traced back to a specific type of nutrient. “Camellia sinensis and herbal teas are rich in antioxidants, particularly polyphenols and flavonoids, which promote multiple health benefits from heart health to metabolic health to brain health,” Yeung says. In fact, polyphenols in tea may help reduce the risk of cardiovascular disease, lower cholesterol and triglyceride levels, improve blood sugar control, and lower cancer risk.

These antioxidants may also boost mood and brain health, depending on the variety. Other elements of the tea-drinking experience, like boosting fluid intake, also bode well for mental health. “Tea is also a good way to hydrate, providing minimal calories in exchange for fluid and healthy compounds,” Hackworth adds. Proper hydration benefits nearly every body system—including the brain and gut—both of which have a significant impact on our mood.

Plus, the act of drinking tea alone can lift your spirits. “Simply sipping a warm cup of tea can feel incredibly calming. It’s a soothing ritual that fits perfectly into an evening wind-down routine, or even works as a quick stress relief strategy whenever you need to pause and reset,” Yeung offers.



Source link

18 12, 2025

Solana Price Prediction: MSCI’s Crypto Treasury Rule Could Lead to $15B in Outflows, DeepSnitch AI Surges Past $830K Despite Market Volatility

By |2025-12-18T21:59:34+02:00December 18, 2025|Crypto News, News|0 Comments

Crypto treasury companies may have to sell off $15B in cryptocurrencies if the MSCI excludes them from its index.

While the list includes 39 companies, Strategy alone could lose $2.8B.

As the “battle with the MSCI” continues, altcoins entered into a deeper correction. With the Solana price prediction entering bear territory, many traders are switching to presales to avoid some of the volatility.

DeepSnitch AI capitalized on these rotations, surging past $830K as retail investors recognized the project’s long-term potential.

Along with the entry of $0.02846 and AI agent deployment, DeepSnitch AI announced exclusive presale codes that could unlock bonuses as high as 100%.

MSCI objections are growing

According to the BitcoinForCorporations group, crypto treasury companies could be forced to sell off massive amounts of cryptocurrencies if they get excluded from MSCI indexes.

The group projects that the outflows could reach a figure of $15B based on the list of 39 companies that will fall under the exclusion rule.

This could put significant pressure on the market, as companies like Strategy alone could see over $2.8B in outflows.

Objections against the proposal are growing, though, as multiple large companies voice their displeasure, which, as of recently, includes Nasdaq-listed Strive.

As retail traders rally against MSCI, they are also looking at Solana price prediction as a metric of potential market recovery. Yet, as short-term prospects are uncertain for most majors, early-stage presales could provide a viable (and more rewarding) alternative.

Coins to look at in Q4

  1. DeepSnitch AI: What’s behind DSNT’s recent presale surge?

DeepSnitch AI raised $830K by December 17, which is much more impressive when you consider that the rest of the market is in the phase of heavy correction.

The lead contributor to bullish performance is the utility itself. DeepSnitch AI is building a sophisticated analytics and prediction suite that leverages five AI agents to predict not only FUD storms, but also the tiniest sentiment shifts, among other things.

DeepSnitch AI is past the idea stage, as the team has announced that the first three AI agents are fully operational and will be made available to early investors soon.

The price of $0.02846 itself also contributes to the 100x narrative suggested by the community. When you put all the fundamentals together, the upside potential is quite high, possibly dwarfing the returns you can achieve with majors (even in the case the Solana price prediction sees a new ATH).

One of the key reasons why the DeepSnitch AI presale snowballed recently is also the exclusive codes valid until January 1 that unlock bonuses between 50 and 100% on large investments.

  1. Solana price prediction: Is a bullish reversal possible in December?

According to CoinMarketCap, Solana traded in the $122 area on December 17, indicating that the overall Solana investor sentiment is bearish.

The 20-day EMA of $133 in a heavy downslope and RSI declining below 39 are further proof of SOL momentum outlook being dominated by bears.

Analysts warn that a dip below the current support line will extend the downward move, making a plunge to $110 followed by closing around $95 likely.

However, once the Solana market indicators start favoring buyers, SOL will likely push beyond the 20-day EMA and pump to $172.

  1. BNB price prediction: Can BNB regain $1K?

On December 17, BNB declined to the $830 level, according to CoinMarketCap.

While it’s significantly more bullish than the Solana price prediction, BNB also failed to regain its 20-day EMA. Thus, analysts believe that the test of the $791 is the next logical move, and if this line breaks, a decline toward $730 is a possibility.

Alternatively, buyers will likely push toward the 20-day EMA of $883 with a successful close, opening the door to a rally toward $1K.

Final words: Bonuses galore

The recent Solana price prediction is a sign of a wider correction. Thus, it’s much safer to dip your toes into brand-new projects, at least until a bullish reversal finally happens.

Raising $830K (and counting), DeepSnitch AI is an outlier in a slow market, which significantly boosts its chances of success and strengthens the popular 100x DSNT narrative.

To take full advantage of the presale, the latest discount codes provide a bonus of 50% for investments above $2K (DSNTVIP50) or 100% for investments above $5K (DSNTVIP100), which is an incredible value for a project already highlighted for its upside potential.

The codes are valid until January 1, so reserve your spot in the DeepSnitch AI presale ASAP. If you’re looking for community updates, feel free to go through X and Telegram.

FAQs

  1. What is the current Solana price prediction?

With SOL trading below $130, the current Solana price prediction remains bearish. If support breaks, analysts warn of a drop toward $110 or even $95 before a potential recovery.

  1. Why is DeepSnitch AI gaining traction during the correction?

DeepSnitch AI raised over $830K despite market volatility, driven by its AI-powered trading and analytics suite, early deployment of live AI agents, and strong 100x upside projections.

  1. What bonuses are available in the DeepSnitch AI presale?

Investors can apply DSNTVIP50 to receive a 50% bonus on investments above $2K, or DSNTVIP100 for a 100% bonus on purchases over $5K. Both bonuses expire on January 1.

 


Disclaimer: This is a Press Release provided by a third party who is responsible for the content. Please conduct your own research before taking any action based on the content.

Source link

18 12, 2025

Polly’s Partner, Pete, Has Prostate Cancer

By |2025-12-18T21:39:52+02:00December 18, 2025|Fitness News, News|0 Comments

Image

Dialogue

Polly and Pete sitting at a dining room table.

Pete has an open binder in front of him.

Polly has a notebook in front of her and she has a pen in her hand.

Polly: We’ve got your list of medications and medical records in the binder. Now let’s write down any questions we have about your prostate cancer diagnosis for your appointment.

Pete: OK, good idea.

Notebook page with questions on it

Questions caregivers may want to ask the HCP:

What treatments are available?

What side effects can we expect?

Can Pete work during treatment?

How do we contact you if we have questions?

Will I be able to care for Pete or will we need in-home help?

SUPER: The next day …

Pete and Polly are sitting in the doctor’s office across from a desk. Polly has the notebook in her lap and her smartphone. They are enjoying each other’s company.

Pete: Thanks for coming with me, Polly. What would I do without you?

Polly: You wouldn’t have remembered the notebook, that’s for sure.

The doctor enters the room and shakes hands.

Doctor: Nice to meet you both.

Pete: I’m Pete.

Polly: I’m Polly, Pete’s partner.

Doctor’s office

Polly: Do you mind if I record our conversation? I know we’ll be going over a lot of important details, and I don’t want to miss anything.

Doctor: Sure! That’s fine with me.

Doctor’s office

Doctor: Pete, I see that we found your prostate cancer during a routine screening. Tell me, are you experiencing any symptoms like frequent urination?

Pete: I don’t think so.

Thought bubbles over Polly of Pete getting up to go to the bathroom during the night (or maybe light under the door of the bathroom?)

Polly: Well, you have been getting up during the night lately.

Pete: Oh you’re right … I didn’t think about nighttime.

Doctor’s office

Doctor: It’s always good when the people around us notice things we don’t, so I’m glad you’re both here and we can work together as a team. Now, let’s go over your treatment plan.

Pete: Great! We also brought a list of questions we have for you.

SUPER: A week later …

Polly and Pete’s house: Polly and Pete are sitting on the couch. The binder and the phone are on the coffee table.

Polly: I updated your medication list with room to jot down any symptoms.

How are you feeling today after treatment?

Pete: I’m really tired. Do you think I should be concerned?

Polly looks at her smartphone.

I think I remember the doctor talking about fatigue … let’s check the recording.

Smartphone playing a voice memo

“Fatigue is a common side effect of the treatment …”

Polly and Pete at the table

Pete: Thanks, that makes me feel better.

Polly: I’ll write it down, and we can bring it up with the doctor if it continues.

A week later …

Doctor’s office

Doctor: How are you feeling, Pete?

Pete: I’ve been really tired since I started treatment.

Doctor: Well, feeling tired is a common side effect.

Doctor’s office

Pete: Polly kept a log and found the fatigue lasts most of the day but is most intense in the afternoon. I’m still exercising and eating — but the fatigue is really affecting my ability to work.

Doctor: Ah, I see. Thanks for letting me know that it’s impacting your everyday life. Let’s try adjusting your medication, and if that doesn’t work, we can try a new one.

Doctor’s office

Pete: That sounds good to me.

Polly: Thank you for listening to our concerns.

Doctor’s office

Doctor: Of course! Good communication helps me help you.

End bar

Caregiver Communication Tips:

Write down questions you have before the appointment.

Take notes or record the office visit.

Be clear and concise about your concerns.

Ask the HCP to clarify anything you don’t understand.

Record and share all physical and mental side effects of treatment.

Establish contacts for follow-up questions and emergency situations.

For more information, please visit HealthyWomen.org



Source link

18 12, 2025

Few Hours Left For Best 5 Crypto Token Listings Today

By |2025-12-18T20:51:32+02:00December 18, 2025|News, NFT News|0 Comments


Top 5 Crypto Token Listings Today: VOOI, BOIL, MOZ, WECAN, JSK Go Live

Key Highlights

  • Five crypto coins are going live on big exchanges today and it creates new trading possibilities.

  • Categories include DeFi, Web3 gaming, EnergyFi, infrastructure, and enterprise blockchain.

  • The current listings are characterized by multiple exchanges, airdrops, and powerful token utilities.

Few Hours Left For Best 5 Crypto Token Listings Today 

On December 18, there are several key crypto listings on Binance Alpha, MEXC, BitMart, Gate.io, KuCoin, and Azbit. In the current day, the DeFi trading, Web3 gaming, and real-yield EnergyFi are receiving high demand in the market.

Overview of 5 Crypto Tokens

  1. VOOI is an everlasting DEX aggregator that enables dealers to get leveraged trading in several decentralized markets through a single interface to enhance liquidity access, execution effectiveness, and the general trading experience.

  2. BoilToken is an EnergyFi project that bridges real-world energy revenues with blockchain, providing staking, governance, and transparent allocation of real yields in a non-inflationary token structure.

  3. Lumoz is a Web3 infrastructure protocol that offers AI computing, zero-knowledge services, scalable decentralized applications, node rewards, and advanced blockchain computation across ecosystems.

  4. Wecan ($WECAN) is a Swiss blockchain platform that aims at secure data sharing, compliance, identity verification, and regulated digital transactions among banks, enterprises, and financial institutions across the globe.

  5. Joysticklabs (JSK) is a Web3 gaming platform that assists developers to create, launch, and scale blockchain games with simple-to-use tools, reward systems, NFTs, and community-driven game economies.

Full Listing Dates & Trading Details of 5 Tokens

1. VOOI Listing Details

  • VOOI Listing Date: December 18, 2025

  • Exchanges: Binance Alpha, KuCoin, Gate.io, MEXC

  • Trading Pairs: VOOI/USDT

  • Gate.io & KuCoin Trading: 13:00 UTC

  • Binance Alpha Airdrop: Starts 12:00 UTC

  • Expected Price: $0.04–$0.06

VOOI is launched on four large platforms at the same time with a high level of initial demand and volatile volatility in the short term.

2. BoilToken ($BOIL) Listing Details

The listing of BOIL is correlated with its presale valuation, providing spot trading to the verified Azbit users with liquidity support and emphasis on the long-term exposure to real yields.

3. Lumoz ($MOZ) Listing Details

  • Lumoz Listing Date: December 18, 2025

  • Exchange: BitMart

  • Trading Pair: MOZ/USDT

  • Trading Time: 10:00 UTC

  • Deposits Open: December 17

Although the listing price is not disclosed, the BitMart launch will provide an important upgrade of MOZ liquidity and global access to users of AI and zero-knowledge infrastructure.

4. Wecan ($WECAN) Listing Details

  • Wecan Listing Date: December 18, 2025

  • Exchange: BitMart

  • Trading Pair: WECAN/USDC

  • Trading Time: 16:00 UTC

  • Initial Launch Price: 0.001 CHF

The list enhances the regulated blockchain presence of Wecan after previous Bitstamp and MEXC integrations, which intensify enterprise-level adoption.

5. Joysticklabs ($JSK) Listing Details

The listing price is not announced, but the MEXC launch will increase the visibility, liquidity, and access of Web3 gaming enthusiasts and developers across the globe.

Tokenomics and Roadmap of 5 Tokens.

1. VOOI Tokenomics and Roadmap

The total supply of VOOI is 1 billion tokens, and 244.21 million are in circulation during its launch. The distribution consists of 31% to the foundation, 27.82% to community growth, 17% to contributors, 13.65% to investors, and 10.53% to airdrops and community sales. 

Source: Website

The roadmap is dedicated to platform upgrades, more intensive liquidity aggregation, governance tools, ecosystem growth, and performance optimization, in order to make perpetual trading more accessible and capital-efficient in decentralized markets.

2. BoilToken (BOIL) Tokenomics and Roadmap.

There are 25 billion tokens that are fixed on the BASE network of BOIL. Distribution is comprised of presale (15%), staking and yield reserves (25%), ecosystem growth (20%), team (10%), treasury and buyback (10%), liquidity (10%) and community incentives (5%). 

BoilToken (BOIL) Token supply

BoilToken (BOIL) Tokenomics

Source: Website

The roadmap involves presale finish, TGE, Azbit and mid-tier CEX listing, staking activation, real-yield payouts, DAO governance rollout and long-term expansion to institutional EnergyFi partnerships.

3. Lumoz ($MOZ) Roadmap & Tokenomics.

There are 10 billion MOZ tokens in total supply of Lumoz. The allocation consists of 25 percent compute and verifier rewards, 18 percent investors, 16 percent contributors, 10 percent ecosystem growth and 6 percent community incentives. 

Lumoz ($MOZ) Tokenomics

Source: Website

MOZ is applied to transaction fees, AI services, zero-knowledge applications, staking and governance through esMOZ. The roadmap has the staking features, NFT integration, launching of the mobile wallet in 2025, expansion of AI ecosystem, and the global partnerships.

4. Wecan ($WECAN) Tokenomics & Roadmap.

WECAN is fixed to 6 billion tokens that are used in blockchain anchoring fees, data hash storage, and validation of transactions on Wecan Chain. A part of all transactions is burnt, which forms a deflationary model. 

Wecan ($WECAN) Tokenomics

Source: Website

Wecan was established in 2015 and released its blockchain and token in 2022, achieving a big listing, and keeps growing internationally. The BitMart listing of 2025 is in favor of enterprise adoption, compliance partnerships, and regulated blockchain developments.

5. Joysticklabs ($JSK) Tokenomics & Roadmap.

The total supply of Joysticklabs is 4 billion JSK tokens distributed in the public sale, team, advisors, ecosystem rewards, staking, treasury, marketing, liquidity, and partnerships. Public sale tokens are unlocked at TGE and other allocations are vested over 1% monthly. 

Joysticklabs ($JSK) Tokenomics

Source: Official JSK Website

The roadmap includes the development of the platform, the launch of the MVP, general testing, NFT tools, cross-chain integration, the integration of staking, and the features of the game aimed at mass adoption of Web3 gaming.

Which Token could Be Successful After Listing?

Opinion: VOOI and Joysticklabs are the best in terms of momentum today. VOOI enjoys the advantage of multi-exchange exposure and the active trading demand, whereas Joysticklabs accesses the rapidly expanding Web3 gaming market. In the short run, it should be volatile, but in the long run, it will be a matter of adoption, utility, and execution.

Conclusion

The current crypto listings are a good indication of high diversity in sectors. Since trading infrastructure to gaming and real-yield assets, December 18 provides traders and investors with new opportunities supported by real use cases.

Disclaimer: This is not financial advice. Please DYOR before investing. CoinGabbar is not responsible for any financial losses. Crypto assets are highly volatile, and you can lose your entire investment.



Source link

18 12, 2025

XRP Price Today (XRP-USD) Holds Near $1.90 as It Battles the $2.00 Line; Forecast and Key Levels for Dec. 18, 2025

By |2025-12-18T20:46:56+02:00December 18, 2025|Forex News, News|0 Comments


XRP’s USD price (XRP-USD) is trading around $1.90–$1.91 on Thursday, December 18, 2025, after another volatile session that briefly pushed the token down toward the mid‑$1.80s and up toward the high‑$1.90s. Across major market trackers, XRP’s 24-hour range has been roughly $1.83 to $1.98—a swing of nearly 8% from low to high, underscoring how jumpy risk assets remain into year‑end. [1]

That volatility is showing up in the broader tape too: bitcoin is still struggling to regain consistent upside traction, while altcoins like XRP are reacting to macro data, ETF flows, and shifting risk appetite almost tick-for-tick. [2]

Below is what’s driving XRP price today, what the latest news and analysis is highlighting on Dec. 18, 2025, and the forecast scenarios traders and investors are watching next.

XRP price today: where XRP-USD stands on Dec. 18, 2025

As of Dec. 18, XRP is quoted near $1.90–$1.91, with notable intraday markers around:

  • 24H low: about $1.83
  • 24H high: about $1.98
  • 24H trading volume (spot): about $3.9B (tracker estimate)
  • All-time high reference: about $3.65, leaving XRP roughly 48% below that peak [3]

The headline level traders keep circling is psychological as much as technical: $2.00. Multiple market reads published today frame the area just below $2 as an “inflection” zone—where rebounds keep failing and where sellers appear to defend exits. [4]

Why XRP is moving today: macro news meets crypto structure

1) Inflation surprise and rate-cut expectations

A major macro catalyst on Dec. 18 has been the latest U.S. inflation read. Reports covering Thursday’s data pointed to cooler-than-expected CPI, which can loosen financial conditions by pulling forward expectations for future rate cuts. In crypto, that often translates into short bursts of relief—especially when positioning is already leaning bearish. [5]

That said, the same coverage also noted uncertainty around the data due to recent disruptions, which helps explain why “good news” hasn’t automatically produced a clean, sustained risk-on rally. [6]

2) Risk appetite is still fragile

Even with pockets of optimism, several analyses argue crypto is trading like a high-beta extension of broader risk markets right now—meaning when investors de-risk (or even hesitate), altcoins tend to feel it first. One market note published this week described XRP as stuck between nearby support and overhead resistance while the wider market remains choppy. [7]

3) Retail participation is weaker, derivatives activity is lighter

One forecast published today emphasized that retail demand has faded, pointing to declining futures open interest as evidence that speculative positioning has cooled compared with earlier in the year. The implication: XRP can still bounce, but sustained rallies may struggle without broader participation returning. [8]

XRP spot ETFs: institutional inflows continue, but price hasn’t “obeyed” yet

One of the most important structural stories for XRP in late 2025 is the emergence of U.S.-listed spot XRP ETFs—and the market is now watching whether those flows can eventually overpower short-term risk-off behavior.

What today’s reports say about ETF flows

Multiple reports published around Dec. 18 cite steady inflows into U.S.-listed XRP spot ETFs:

  • Roughly $18–$19 million of net inflows reported for Wednesday (Dec. 17, U.S. time)
  • Cumulative net inflows around $1.03 billion
  • Net assets around $1.14 billion [9]

A separate analysis this week argued that spot XRP ETFs had built ~$1.01B in net inflows in their early weeks, but still represent a relatively small slice of XRP’s overall market cap—suggesting more “room” for institutional allocation if the category keeps maturing. [10]

Which products are in the mix

One of the clearest, primary-source confirmations comes from Bitwise, which announced its Bitwise XRP ETF would start trading on NYSE on Nov. 20, 2025 under ticker XRP, holding spot XRP and charging a stated management fee (with an initial waiver structure described in the release). [11]

Separately, reports around the broader ETF rollout noted earlier launches and additional listings, including an initial U.S. spot XRP ETF approval and trading start in mid‑November. [12]

Why this matters for price forecasts: ETF flows can be supportive over time, but they don’t guarantee a straight-line move. In the short run, macro risk, profit-taking, and technical breaks can outweigh steady inflows—especially if the market is leaning defensive into year-end.

Ripple-related headlines today: institutional rails keep expanding

XRP’s market narrative is tightly linked to Ripple (the company), even though XRP trades freely on exchanges and is not “a Ripple stock.” On Dec. 18, two notable Ripple-related headlines added to the institutional backdrop:

Ripple expands partnership with TJM

Ripple announced an expanded partnership with TJM Investments / TJM Institutional Services, describing infrastructure support for execution and clearing services and stating Ripple has invested in TJM. The release frames this as part of Ripple Prime’s institutional push (including expectations of expanded digital-asset coverage). [13]

VivoPower’s Ripple-share deal pitched as “indirect XRP exposure”

Decrypt reported that VivoPower plans to originate up to $300 million in Ripple Labs shares for an investment vehicle, pitching that equity exposure as implying indirect exposure to roughly 450 million XRP at current prices (valued around $900 million in the article’s framing). [14]

These kinds of stories don’t automatically move XRP day-to-day—but they contribute to the broader theme that more vehicles are being built to express XRP-related exposure through regulated or traditional wrappers.

Regulation watch: OCC trust bank approval is a real catalyst—still pending final sign-off

One of the most consequential regulatory developments in December is that the U.S. Office of the Comptroller of the Currency (OCC) granted conditional approval for Ripple (and other crypto firms) to establish a national trust bank. Importantly, Reuters notes these charters still require final approval before the trust banks can operate, and they do not allow deposit-taking or lending like a full commercial bank. [15]

For XRP market participants, the key signal isn’t “banking magic,” it’s the direction of travel: deeper integration of crypto infrastructure into the regulated financial system—paired with ongoing political and industry debate about standards and risk. [16]

XRP-USD technical outlook: the levels analysts are watching now

Across today’s forecast notes and analyses, the market is converging around a few key zones.

Immediate support: $1.90, then ~$1.82

  • Several analyses describe $1.90 as the near-term “line in the sand” during recent consolidation.
  • A widely cited next support sits around $1.82, which has been described as a key level holding the structure together. [17]

Downside targets if $1.82 fails

Different analyses cite different downside waypoints, but the recurring idea is simple: a clean break below $1.82 increases the odds of a deeper flush.

  • One market note cited a potential extension toward the mid‑$1.60s (with specific downside markers discussed around ~$1.64). [18]
  • Another market update suggested the trend could stretch toward $1.61 in a bearish continuation scenario. [19]

Resistance: $2.00 first, then $2.20–$2.30

On the upside, the “prove it” level remains $2.00. Analysts broadly frame a reclaim-and-hold above $2 as the first step toward stabilizing.

Above that, one analysis highlights a heavier resistance zone around $2.20–$2.30, describing XRP as having spent weeks trapped beneath it. [20]

XRP price forecast: scenarios for the days and weeks ahead

Because crypto markets can pivot hard on macro headlines (and XRP can overshoot in either direction), the most responsible forecast is scenario-based. Here’s what today’s reports imply.

Scenario A: Base case (range-bound with a bearish lean)

If broader risk appetite remains fragile into late December, XRP may continue chopping between roughly $1.82 and $2.00, with rallies selling off near resistance and buyers defending the lower band. This aligns with commentary emphasizing weakened retail participation and the market’s difficulty turning ETF inflows into immediate upside. [21]

Scenario B: Bear case (breakdown below $1.82)

If XRP loses ~$1.82 decisively—especially on rising volatility—several analyses suggest the market could probe lower into the $1.60s. In this path, ETF inflows may slow the decline but not necessarily stop it if macro conditions worsen or bitcoin sells off further. [22]

Scenario C: Bull case (reclaim $2.00 and build above it)

A bullish reversal likely requires a combination of:

  • Improving macro sentiment (e.g., rate-cut expectations strengthening after softer inflation),
  • Sustained ETF inflows, and
  • A clean reclaim of $2.00, followed by pressure on the $2.20–$2.30 zone.

This is the “prove the bottom” scenario: if it happens, today’s analysis suggests XRP could transition from “damage control” into a more constructive recovery phase. [23]

What to watch next (the catalysts that can move XRP-USD)

Looking beyond the next candle, XRP traders are likely to keep focusing on:

  • Daily XRP spot ETF flow updates (whether inflows persist, accelerate, or finally stall). [24]
  • Follow-through in U.S. macro data and the market’s confidence in the inflation trend and rate-cut path. [25]
  • Regulatory milestones tied to Ripple’s conditional OCC trust bank approval (any movement toward final approval, or added conditions). [26]
  • Institutional expansion headlines (prime brokerage, execution/clearing partnerships, and equity-linked structures referencing XRP exposure). [27]

Bottom line

On Dec. 18, 2025, XRP price today (XRP-USD) is hovering near $1.90, still struggling to reclaim $2.00 even as the institutional “plumbing” around XRP appears to be expanding—via spot XRP ETFs with roughly ~$1B+ in cumulative net inflows and a drumbeat of Ripple institutional announcements. [28]

The near-term forecast comes down to a simple battle: hold $1.82–$1.90 support or risk a deeper slide, versus reclaim $2.00 and build a base strong enough to challenge the next resistance band. [29]

XRP Price Predictions: Could It Reach $1000?

References

1. www.coingecko.com, 2. www.tmgm.com, 3. www.coingecko.com, 4. www.fxstreet.com, 5. www.investors.com, 6. www.investors.com, 7. www.investing.com, 8. www.fxstreet.com, 9. www.fxstreet.com, 10. www.investing.com, 11. bitwiseinvestments.com, 12. finance.yahoo.com, 13. www.businesswire.com, 14. decrypt.co, 15. www.reuters.com, 16. www.reuters.com, 17. www.fxstreet.com, 18. www.investing.com, 19. www.tmgm.com, 20. www.investing.com, 21. www.fxstreet.com, 22. www.investing.com, 23. www.investors.com, 24. www.fxstreet.com, 25. www.investors.com, 26. www.reuters.com, 27. www.businesswire.com, 28. www.coingecko.com, 29. www.fxstreet.com



Source link

Go to Top